Iowa House Advances Psilocybin PTSD Treatment Bill

Legislation would allow supervised psilocybin therapy for individuals diagnosed with post-traumatic stress disorder.

Mar. 23, 2026 at 10:03pm

Got story updates? Submit your updates here. ›

A bill addressing the use of psilocybin for post-traumatic stress disorder has advanced in the Iowa House. The proposal would allow the production and supervised administration of psilocybin, a psychedelic compound found in certain mushrooms, for individuals diagnosed with PTSD. Patients would receive treatment in a controlled setting with a licensed counselor present.

Why it matters

While psilocybin remains a federally restricted substance, some states that have implemented similar programs have reported reductions in the effects of PTSD following treatment. This legislation represents a potential new approach to addressing mental health challenges like PTSD.

The details

House File 620 moved through both subcommittee and full committee last week. Under the bill, patients would receive psilocybin treatment in a controlled setting with a licensed counselor present for the duration of the session, which could last up to six hours.

  • The bill advanced in the Iowa House on March 23, 2026.

The players

Dennis Guth

A Republican state representative from Klemme, Iowa who authored the newsletter 'The View from Here' discussing the bill's progress.

Got photos? Submit your photos here. ›

What they’re saying

“Because psilocybin remains a federally restricted substance, research is still limited. However, some states that have implemented similar programs have reported reductions in the effects of PTSD following treatment.”

— Dennis Guth, State Representative

What’s next

The bill will now move to the full Iowa House for further consideration.

The takeaway

This legislation represents a potential new approach to addressing mental health challenges like PTSD, though the use of psilocybin remains federally restricted and research is still limited.